complete pathological response breast cancer

Release time ：Dec-23,2024

A complete pathological response in breast cancer is defined as the absence of viable cancer cells in tumor tissue after neoadjuvant therapy, as determined by pathological examination. This typically signifies a favorable treatment outcome and a higher likelihood of survival.

During the treatment of breast cancer, the goal of neoadjuvant therapy, which may include chemotherapy, radiotherapy, or targeted therapy, is to reduce tumor size or eradicate cancer cells, thereby increasing the success rate of surgical removal and improving patient survival. When a patient has undergone neoadjuvant therapy and the surgically removed tumor tissue shows no viable cancer cells upon pathological review, this indicates a complete pathological response. Such an outcome is indicative of a highly effective treatment, and patients generally have a better prognosis.

For breast cancer patients who have achieved a complete pathological response, despite the significant therapeutic success, it is crucial to continue close monitoring and adhere to the physician's recommendations for further treatment and follow-up. Moreover, patients should maintain a healthy lifestyle, including a balanced diet, regular exercise, abstaining from smoking, and limiting alcohol consumption, to minimize the risk of recurrence. At all times, patients must comply with prescribed medication regimens and avoid self-medicating without medical guidance.